title: Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial".
authors.forename: Walter C
authors.initials: WC
authors.lastname: Willett
authors.forename: JoAnn E
authors.initials: JE
authors.lastname: Manson
authors.forename: Francine
authors.initials: F
authors.lastname: Grodstein
authors.forename: Meir J
authors.initials: MJ
authors.lastname: Stampfer
authors.forename: Graham A
authors.initials: GA
authors.lastname: Colditz
mesh_terms: D000368:Aged; D015982:Bias; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control; D015986:Confounding Factors, Epidemiologic; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage; D005260:Female; D006801:Humans; D015994:Incidence; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D008875:Middle Aged; D019370:Observation; D017698:Postmenopause; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D012959:Socioeconomic Factors; D013997:Time Factors; D014481:United States / Q000453:epidemiology
chemical_list: D004966:Estrogens, Conjugated (USP); D017258:Medroxyprogesterone Acetate